Selected research
Market Structure
Global HER2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global HER2 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of HER2 Antibody include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global HER2 Antibody market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of HER2 Antibody and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents HER2 Antibody revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the HER2 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.
HER2 Antibody Segment by Company
Novartis AG
Pfizer
InvivoGen
Genentech Inc
Celltrion
Bio-Techne
Biocon Limited
Abnova Corporation
HER2 Antibody Segment by Type
Ado-trastuzumab Emtansine
Lapatinib
Pertuzumab
Trastuzumab
Everolimus
HER2 Antibody Segment by Application
Hospital
Medical Center
HER2 Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HER2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of HER2 Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HER2 Antibody industry.
Chapter 3: Detailed analysis of HER2 Antibody companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HER2 Antibodyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ado-trastuzumab Emtansine
- Lapatinib
- Pertuzumab
- Trastuzumab
- Everolimus
Applications
- Hospital
- Medical Center
Companies covered
- Novartis AG
- Pfizer
- InvivoGen
- Genentech Inc
- Celltrion
- Bio-Techne
- Biocon Limited
- Abnova Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global HER2 Antibody Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Ado-trastuzumab Emtansine
- 1.2.3 Lapatinib
- 1.2.4 Pertuzumab
- 1.2.5 Trastuzumab
- 1.2.6 Everolimus
- 1.3 Market Analysis by Application
- 1.3.1 Global HER2 Antibody Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Medical Center
- 1.4 Global Market Growth Prospects
- 1.5 Global HER2 Antibody Growth Trends by Region
- 1.5.1 Global HER2 Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 HER2 Antibody Market Size by Region (2021-2026)
- 1.5.3 HER2 Antibody Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global HER2 Antibody Market Dynamics
- 2.1 HER2 Antibody Industry Trends
- 2.2 HER2 Antibody Industry Drivers
- 2.3 HER2 Antibody Industry Opportunities and Challenges
- 2.4 HER2 Antibody Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global HER2 Antibody Revenue by Company (2021-2026)
- 3.2 Global HER2 Antibody Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global HER2 Antibody Key Company Head office and Area Served
- 3.4 Global HER2 Antibody Company, Product Type & Application
- 3.5 Global HER2 Antibody Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global HER2 Antibody Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 HER2 Antibody Players Market Share by Revenue in 2025
- 3.6.3 2025 HER2 Antibody Tier 1, Tier 2, and Tier 3
4 HER2 Antibody Market by Type
- 4.1 Global HER2 Antibody Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global HER2 Antibody Market Size by Type (2021-2032)
- 4.3 Global HER2 Antibody Market Size Share by Type (2021-2032)
5 HER2 Antibody Market by Application
- 5.1 Global HER2 Antibody Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global HER2 Antibody Market Size by Application (2021-2032)
- 5.3 Global HER2 Antibody Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Novartis AG
- 6.1.1 Novartis AG Company Information
- 6.1.2 Novartis AG Business Overview
- 6.1.3 Novartis AG HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Novartis AG HER2 Antibody Product Portfolio
- 6.1.5 Novartis AG Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Pfizer HER2 Antibody Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 InvivoGen
- 6.3.1 InvivoGen Company Information
- 6.3.2 InvivoGen Business Overview
- 6.3.3 InvivoGen HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 InvivoGen HER2 Antibody Product Portfolio
- 6.3.5 InvivoGen Recent Developments
- 6.4 Genentech Inc
- 6.4.1 Genentech Inc Company Information
- 6.4.2 Genentech Inc Business Overview
- 6.4.3 Genentech Inc HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Genentech Inc HER2 Antibody Product Portfolio
- 6.4.5 Genentech Inc Recent Developments
- 6.5 Celltrion
- 6.5.1 Celltrion Company Information
- 6.5.2 Celltrion Business Overview
- 6.5.3 Celltrion HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Celltrion HER2 Antibody Product Portfolio
- 6.5.5 Celltrion Recent Developments
- 6.6 Bio-Techne
- 6.6.1 Bio-Techne Company Information
- 6.6.2 Bio-Techne Business Overview
- 6.6.3 Bio-Techne HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bio-Techne HER2 Antibody Product Portfolio
- 6.6.5 Bio-Techne Recent Developments
- 6.7 Biocon Limited
- 6.7.1 Biocon Limited Company Information
- 6.7.2 Biocon Limited Business Overview
- 6.7.3 Biocon Limited HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Biocon Limited HER2 Antibody Product Portfolio
- 6.7.5 Biocon Limited Recent Developments
- 6.8 Abnova Corporation
- 6.8.1 Abnova Corporation Company Information
- 6.8.2 Abnova Corporation Business Overview
- 6.8.3 Abnova Corporation HER2 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Abnova Corporation HER2 Antibody Product Portfolio
- 6.8.5 Abnova Corporation Recent Developments
7 North America
- 7.1 North America HER2 Antibody Market Size (2021-2032)
- 7.2 North America HER2 Antibody Market Size by Type
- 7.2.1 North America HER2 Antibody Market Size by Type (2021-2026)
- 7.2.2 North America HER2 Antibody Market Size by Type (2027-2032)
- 7.2.3 North America HER2 Antibody Market Share by Type (2021-2032)
- 7.3 North America HER2 Antibody Market Size by Application
- 7.3.1 North America HER2 Antibody Market Size by Application (2021-2026)
- 7.3.2 North America HER2 Antibody Market Size by Application (2027-2032)
- 7.3.3 North America HER2 Antibody Market Share by Application (2021-2032)
- 7.4 North America HER2 Antibody Market Size by Country
- 7.4.1 North America HER2 Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America HER2 Antibody Market Size by Country (2021-2026)
- 7.4.3 North America HER2 Antibody Market Size by Country (2027-2032)
- 7.4.4 North America HER2 Antibody Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe HER2 Antibody Market Size (2021-2032)
- 8.2 Europe HER2 Antibody Market Size by Type
- 8.2.1 Europe HER2 Antibody Market Size by Type (2021-2026)
- 8.2.2 Europe HER2 Antibody Market Size by Type (2027-2032)
- 8.2.3 Europe HER2 Antibody Market Share by Type (2021-2032)
- 8.3 Europe HER2 Antibody Market Size by Application
- 8.3.1 Europe HER2 Antibody Market Size by Application (2021-2026)
- 8.3.2 Europe HER2 Antibody Market Size by Application (2027-2032)
- 8.3.3 Europe HER2 Antibody Market Share by Application (2021-2032)
- 8.4 Europe HER2 Antibody Market Size by Country
- 8.4.1 Europe HER2 Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe HER2 Antibody Market Size by Country (2021-2026)
- 8.4.3 Europe HER2 Antibody Market Size by Country (2027-2032)
- 8.4.4 Europe HER2 Antibody Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China HER2 Antibody Market Size (2021-2032)
- 9.2 China HER2 Antibody Market Size by Type
- 9.2.1 China HER2 Antibody Market Size by Type (2021-2026)
- 9.2.2 China HER2 Antibody Market Size by Type (2027-2032)
- 9.2.3 China HER2 Antibody Market Share by Type (2021-2032)
- 9.3 China HER2 Antibody Market Size by Application
- 9.3.1 China HER2 Antibody Market Size by Application (2021-2026)
- 9.3.2 China HER2 Antibody Market Size by Application (2027-2032)
- 9.3.3 China HER2 Antibody Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia HER2 Antibody Market Size (2021-2032)
- 10.2 Asia HER2 Antibody Market Size by Type
- 10.2.1 Asia HER2 Antibody Market Size by Type (2021-2026)
- 10.2.2 Asia HER2 Antibody Market Size by Type (2027-2032)
- 10.2.3 Asia HER2 Antibody Market Share by Type (2021-2032)
- 10.3 Asia HER2 Antibody Market Size by Application
- 10.3.1 Asia HER2 Antibody Market Size by Application (2021-2026)
- 10.3.2 Asia HER2 Antibody Market Size by Application (2027-2032)
- 10.3.3 Asia HER2 Antibody Market Share by Application (2021-2032)
- 10.4 Asia HER2 Antibody Market Size by Country
- 10.4.1 Asia HER2 Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia HER2 Antibody Market Size by Country (2021-2026)
- 10.4.3 Asia HER2 Antibody Market Size by Country (2027-2032)
- 10.4.4 Asia HER2 Antibody Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa HER2 Antibody Market Size (2021-2032)
- 11.2 South America, Middle East & Africa HER2 Antibody Market Size by Type
- 11.2.1 South America, Middle East & Africa HER2 Antibody Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa HER2 Antibody Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa HER2 Antibody Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa HER2 Antibody Market Size by Application
- 11.3.1 South America, Middle East & Africa HER2 Antibody Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa HER2 Antibody Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa HER2 Antibody Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa HER2 Antibody Market Size by Country
- 11.4.1 South America, Middle East & Africa HER2 Antibody Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa HER2 Antibody Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa HER2 Antibody Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa HER2 Antibody Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst